First Page | Document Content | |
---|---|---|
![]() Date: 2014-09-10 10:15:50Organic chemistry Ketones Oncology 5-HT3 antagonist Drug discovery Chemotherapy Ondansetron Aprepitant Methadone Medicine Chemistry Antiemetics | Add to Reading List |
![]() | P11444 - ASCO2014 MEC and HECDocID: 1a4Ek - View Document |
![]() | P11444 - ASCO2014 MEC and HECDocID: 19OCx - View Document |
![]() | Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“AstellaDocID: 19AF1 - View Document |
![]() | P11444 - ASCO2014 MEC and HECDocID: 199Dl - View Document |
![]() | P11444 - ASCO2014 MEC and HECDocID: 1987o - View Document |